Impact of Genetic Defects on Coronary Atherosclerosis among Turkish Cypriots

Cenk Conkbayir1, Rezan Fahrioglu Yamaci2, Pinar Gencer2

  • 1Department of Cardiology, Near East University, Nicosia, Cyprus.

The Heart Surgery Forum
|November 1, 2017
PubMed

Insights

Genetic variants show no direct link to coronary artery disease in Turkish Cypriots. Instead, lifestyle factors like diabetes and obesity appear more influential in this population. Further research into these secondary factors is recommended.

Area of Science:

  • Cardiovascular Genetics
  • Population Genetics
  • Metabolic Disorders

Background:

  • Coronary artery disease (CAD) susceptibility and genetic variants in Turkish Cypriots remain understudied.
  • This research investigates genetic variants related to blood coagulation, glucose, and lipid metabolism in Turkish Cypriots with CAD.
  • Results are compared with Turkish patients from Turkey to identify population-specific genetic associations.

Purpose of the Study:

  • To investigate the distribution of specific gene variants in Turkish Cypriots with coronary artery disease.
  • To explore associations between clinical parameters and genes involved in coagulation, glucose, and lipid metabolism.
  • To compare genetic findings between Turkish Cypriots and Turkish patients from Turkey.

Main Methods:

  • Study included 187 individuals with CAD (87 Turkish Cypriots, 100 Turks from Turkey).
  • Coronary angiography confirmed CAD diagnosis.
  • Genetic analysis focused on variants: FV Leiden, FVR2, PTH, FXIII, beta-Fibrinogen, PAI-1, HPA1, MTHFR (C677T, A1298C), ACE, Apo B, and Apo E.

Main Results:

  • Age, male sex, diabetes, hyperlipidemia, and triglyceride/HDL ratio were significant risk factors in Turkish Cypriots.
  • MTHFR [C677T] variant was marginally higher in Turkish Cypriots compared to Turks (P=0.06).
  • No direct gene variant association with CAD was found; however, indirect links to risk factors were observed (e.g., MTHFR [A1298C] with low HDL, HPA-1 a/b with high total cholesterol).

Conclusions:

  • Secondary factors like diabetes, hypertension, obesity, and sedentary lifestyle may play a more significant role in CAD among Turkish Cypriots than direct genetic factors.
  • The study highlights the importance of considering lifestyle modifications for CAD prevention in this population.
  • Further research is needed to elucidate the complex interplay between genetics and environmental factors in Turkish Cypriot CAD patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
25
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
18
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
24
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
20
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
646